Nordea Investment Management Reduces McKesson Holdings

Institutional investor decreases stake in pharmaceutical distributor by 2% in Q4 2025

Mar. 22, 2026 at 10:07am

Got story updates? Submit your updates here. ›

Nordea Investment Management AB, a major institutional investor, decreased its holdings in shares of McKesson Corporation (NYSE:MCK) by 2.0% in the fourth quarter of 2025, according to the company's recent Form 13F filing with the Securities & Exchange Commission. Nordea Investment Management AB now owns 1,071,733 shares of the company's stock, worth approximately $885,251,000, making it the 25th largest holding in the firm's portfolio.

Why it matters

As one of the largest institutional investors in McKesson, Nordea's decision to reduce its stake in the pharmaceutical distributor could signal a shift in market sentiment around the company. McKesson's stock performance and the trading activity of major investors are closely watched by analysts and the broader market.

The details

Nordea Investment Management AB sold 21,798 shares of McKesson during the fourth quarter, reducing its overall position by 2.0%. The firm now owns approximately 0.87% of McKesson's outstanding shares. McKesson is a leading pharmaceutical distributor and healthcare services company, supplying pharmaceuticals, medical-surgical products, and technology solutions to pharmacies, hospitals, and other healthcare providers.

  • Nordea Investment Management AB filed its Form 13F for the fourth quarter of 2025 on March 22, 2026.

The players

Nordea Investment Management AB

A major institutional investor and asset management firm based in the Nordic region.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and technology solutions to healthcare providers.

Got photos? Submit your photos here. ›

The takeaway

Nordea's reduction in its McKesson holdings could signal broader market concerns about the company's performance or outlook, though the reasons behind the decision are not entirely clear. Investors and analysts will likely continue to monitor McKesson's stock and the trading activity of major institutional investors like Nordea.